Neuronetics is trading 7.1% up today at $2.10, extending a rebound that began in late July as speculative interest remains high.
- The move occurs despite a lack of fresh company-specific headlines or filings, suggesting the price action is driven by trader engagement and technical momentum.
- Gains are further supported by a broader risk-on backdrop in U.S. equities, characterized by modest gains in major indexes and easing market volatility.